Spyre Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYRE and other ETFs, options, and stocks.About SYRE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
SYRE Key Statistics
Stock Snapshot
Spyre Therapeutics(SYRE) stock is priced at $105.33, giving the company a market capitalization of 10.26B. It carries a P/E multiple of -48.32.
On 2026-08-11, Spyre Therapeutics(SYRE) stock opened at $104.85, reached a high of —, and a low of —.
The Spyre Therapeutics(SYRE)'s current trading volume is 0, compared to an average daily volume of 877.45K.
During the past year, Spyre Therapeutics(SYRE) stock moved between $14.51 at its lowest and $108.14 at its peak.
During the past year, Spyre Therapeutics(SYRE) stock moved between $14.51 at its lowest and $108.14 at its peak.
Analyst ratings
94%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.